Filing Details

Accession Number:
0001209191-15-030755
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-04-01 16:26:37
Reporting Period:
2015-03-30
Filing Date:
2015-04-01
Accepted Time:
2015-04-01 16:26:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
879169 Incyte Corp INCY Services-Commercial Physical & Biological Research (8731) 943136539
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1607052 M Reid Huber 1801 Augustine Cut-Off
Wilmington DE 19803
Evp, Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-03-30 17,499 $18.32 61,907 No 4 M Direct
Common Stock Acquisiton 2015-03-30 16,764 $17.79 78,671 No 4 M Direct
Common Stock Disposition 2015-03-30 10,000 $93.67 68,671 No 4 S Direct
Common Stock Disposition 2015-03-30 8,000 $93.61 60,671 No 4 S Direct
Common Stock Disposition 2015-03-30 7,000 $93.66 53,671 No 4 S Direct
Common Stock Disposition 2015-03-30 5,000 $93.67 48,671 No 4 S Direct
Common Stock Disposition 2015-03-30 4,263 $93.75 44,408 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2015-03-30 17,499 $0.00 17,499 $18.32
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2015-03-30 16,764 $0.00 16,764 $17.79
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
21,709 2020-02-08 No 4 M Direct
0 2019-01-18 No 4 M Direct
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
  2. Reporting person undertakes to provide upon request by Securites and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated.
  3. Represents weighted average sale price. Actual sale prices ranged from $92.67 - $96.00.
  4. Represents weighted average sale price. Actual sale prices ranged from $92.67 - $96.05.
  5. Represents weighted average sale price. Actual sale prices ranged from $92.67 - $96.00.
  6. Represents weighted average sale price. Actual sale prices ranged from $92.78 - $96.00.
  7. Represents weighted average sale price. Actual sale prices ranged from $92.67 - $96.00.
  8. Beginning February 9, 2013, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.
  9. Beginning January 19, 2012, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.